Idexx Laboratories Other — Total consolidated revenue remained flat by 0.0% to $31.09M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.0%, from $27.53M to $31.09M. Over 4 years (FY 2021 to FY 2025), Other — Total consolidated revenue shows a downward trend with a -7.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests successful market expansion or rising demand in secondary regions, while a decrease may indicate market saturation or strategic divestment.
This metric represents the total revenue generated by the company's geographic or operational segment categorized as 'Ot...
Peers often report similar 'Other' or 'Rest of World' segments, though the composition varies significantly based on how companies define their primary reporting regions.
idxx_segment_other_total_consolidated_revenue| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $167.53M | $161.58M | $176.40M | $110.10M | $124.36M |
| YoY Change | — | -3.6% | +9.2% | -37.6% | +13.0% |